ERA PerMed is a new ERA-Net Cofund, supported by 32 partners from 23 countries and cofunded by the European Commission. To align national research strategies, promote excellence, reinforce the competitiveness of European players in PM, and enhance the European collaboration with non-EU countries, national funding organisations have agreed to launch Joint Transnational Calls for collaborative innovative research projects in Personalised Medicine (PM).
Coordinator: Nacional Institute of Health Carlos III – Instituto de Salud Carlos III
Please have a look to the videos of the video competition of cofunded JTC2018 projects. “The story behind our personalised medicine research project” of cofunded JTC2018 projects.
ERA PerMed is finalising its journey, but the new launched European Partnership on Personalised Medicine (EP PerMed) is continuing offering funding opportunities in the field of personalised medicine research. Please have a look at the preannouncement of their first Joint Transnational Call 2024.
We invite you to have a look to our ERA PerMed Final Brochure in which your will encounter more details of the results achieved by ERA PerMed in its lifetime.
ERA PerMed consortium partners (NSC)
Austrian Science Fund, (FWF)
AUSTRIA
Fund for Scientific Research, (FNRS)
BELGIUM
Canadian Institutes of Health Research, (CIHR)
CAMADA
Fonds de recherche du Québec – Santé, (FRQS)
CANADA (QUEBEC)
Ministry of Science and Education of the Republic of Croatia, (MSE)
CROATIA |
Innovation Fund Denmark, (InnoFond)
DENMARK
Estonian Research Council, (ETAg)
ESTONIA
Estonian Ministry of Social Affairs, (MSA)
ESTONIA
Academy of Finland, (AKA)
FINLAND
Agence Nationale de la Recherche, (ANR)
FRANCE
Federal Ministry of Education and Research, (BMBF) German Aerospace Centre e.V. – Programme Management Agency, (DLR)
GERMANY
Federal Ministry of Health, (BMG)
GERMANY
Saxon State Ministry for Higher Education, Research and the Arts, (SMWK)
GERMANY (SACHSEN)
National Research, Development and Innovation Office, (NKFIH)
HUNGARY
Health Research Board, (HRB)
IRELAND
Chief Scientist Office, Ministry Of Health, (CSO-MOH)
ISRAEL
Italian Ministry of Health, (IT-MoH)
ITALY
Regional Foundation for Biomedical Research, (FRRB)
ITALY (LOMBARDY)
State Education Development Agency (VIAA)
National Research Fund, (FNR)
LUXEMBOURG
The Research Council of Norway, (RCN)
NORWAY
National Centre for Research and Development, (NCBR)
POLAND
Executive Agency for Higher Education, Research, Development and Innovation Funding, (UEFISCDI)
ROMANIA
Ministry of Education, Science and Sport, (MIZS)
SLOVENIA
National Institute of Health Carlos III (ISCIII)
Centro Tecnológico Industrial (CDTI)
SPAIN
Health Department– Generalitat de Cataluña (DS-CAT)
Government of Navarre, (GN)
SPAIN (NAVARRE)
Swedish Research Council, (SRC)
SWEDEN
The Netherlands Organisation for Health Research and Development, (ZonMw)
THE NETHERLANDS
The Scientific and Technological Research Council of Turkey, (TUBITAK)
TURKEY